Letter: A better way to spend Ineos’ Oxford gift
After reading “Ratcliffe’s Ineos makes £100m Oxford donation to tackle antibiotic resistance” (Report, January 19), my first thought was if half as much money was invested in preventive practice in human primary care and animal welfare, antimicrobial resistance (AMR) would be substantially de-fuelled, giving Ineos, Oxford university and others a much longer runway to get next-generation cures developed, trialled, peer reviewed and commercialised.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.